464 related articles for article (PubMed ID: 18495651)
21. Effect of antifungal treatment in a murine model of blastoschizomycosis.
Serena C; Mariné M; Marimon R; Pastor FJ; Guarro J
Int J Antimicrob Agents; 2007 Jan; 29(1):79-83. PubMed ID: 17134881
[TBL] [Abstract][Full Text] [Related]
22. Lack of activity of amphotericin B in systemic murine fusarial infection.
Anaissie EJ; Hachem R; Legrand C; Legenne P; Nelson P; Bodey GP
J Infect Dis; 1992 Jun; 165(6):1155-7. PubMed ID: 1583339
[TBL] [Abstract][Full Text] [Related]
23. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Ruíz-Cendoya M; Pastor J; Guarro J
Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
[TBL] [Abstract][Full Text] [Related]
24. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
25. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
26. Comparison of antifungal treatments for murine fusariosis.
Spellberg B; Schwartz J; Fu Y; Avanesian V; Adler-Moore J; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2006 Nov; 58(5):973-9. PubMed ID: 16973654
[TBL] [Abstract][Full Text] [Related]
27. A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Selleslag D
Acta Biomed; 2006; 77 Suppl 2():32-5. PubMed ID: 16918066
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
[TBL] [Abstract][Full Text] [Related]
29. [Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Muramatsu T; Ueki T; Ohashi K; Negishi K; Suzuki T; Shitara M; Honma M; Ito T; Sakai M; Yamashita T; Akiyama H; Sakamaki H
Rinsho Ketsueki; 2006 Aug; 47(8):753-7. PubMed ID: 16986714
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
32. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
33. Alternatives to amphotericin B for Candida rugosa infection.
Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
[TBL] [Abstract][Full Text] [Related]
34. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
[TBL] [Abstract][Full Text] [Related]
35. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
36. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Heyn K; Tredup A; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
[TBL] [Abstract][Full Text] [Related]
38. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Fanci R; Pini G; Bartolesi AM; Pecile P
Rev Iberoam Micol; 2013 Jan; 30(1):51-3. PubMed ID: 22659590
[TBL] [Abstract][Full Text] [Related]
39. [New development in the treatment of deep-seated mycoses].
Maesaki S
Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1993-8. PubMed ID: 17929445
[No Abstract] [Full Text] [Related]
40. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]